Castuner

Foundation Fighting Blindness

Foundation Fighting Blindness

The Foundation Fighting Blindness is the driving force in the global development of treatments and cures for blinding diseases. To learn more, go to FightingBlindness.org.

Podcast website

Listen in your app

Episodes

276 episodes

  1. Eye on the Cure Podcast | Episode 105: A Race Against Blindness 1:03:24
  2. Emerging gene therapy for RDH12-associated Leber congenital amaurosis cleared for clinical trials 2:29
  3. Eye on the Cure | Episode 104: Dr. Daniel Chung – Emerging XLRP gene therapy shows promising results 37:43
  4. PRPH2 Workshop 2026: Day 1 Keynote – John Samuel 32:57
  5. Early clinical trial results show vision gains in patients with BEST1-related disease 4:11
  6. Beacon's emerging XLRP gene therapy improves low-light vision in phase 3 trial 4:26
  7. Nanoscope’s investigational RP treatment MOGENRY advances toward FDA approval 5:25
  8. Eye on the Cure Podcast | Episode 103: Kenyetta McCurdy-Byrd and Heather Edwards 50:26
  9. First patient treated with potential retinitis pigmentosa treatment from Sumitomo Pharma America 2:25
  10. Tarsus plans to purchase Alkeus, developer of emerging Stargardt treatment 3:15
  11. PRIMA retinal implant restores sight in patients with geographic atrophy from AMD 3:49
  12. FDA accepts new drug application, prioritizes review for potential Stargardt treatment 4:30
  13. Eye on the Cure Podcast | Episode 102: What is Venture Philanthropy? 30:05
  14. Sepul Bio completes clinical trial enrollment for its USH2A retinitis pigmentosa treatment 3:25
  15. FDA approves Lumvoa, a new treatment for thyroid eye disease 5:14
  16. Belite Bio submits new drug application to FDA for its Stargardt treatment 3:05
  17. Eye on the Cure Podcast | Episode 101: Dr. Patrick Staropoli 42:21
  18. Potential Oral Stargardt Treatment Advances to Phase 3 Clinical Trial 4:57
  19. Foundation Fighting Blindness Celebrates Bennett, Maguire, and High's Breakthrough Prize for Revolutionary Gene Therapy 4:01
  20. Atsena Therapeutics Advances to Pivotal Phase 3 Trial for X-Linked Retinoschisis 3:21
  21. MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP) 3:13
  22. Opus Genetics Secures $155 Million Financing to Accelerate Gene Therapy Pipeline 2:41
  23. VeonGen Reports Promising Clinical Progress for Stargardt Disease Gene Therapy 2:49
  24. Sumitomo Pharma Receives FDA Orphan Drug Designation for Retinitis Pigmentosa Treatment 2:12
  25. Octant Bio Begins Clinical Testing Oral Treatment for Rhodopsin-Related Retinitis Pigmentosa 2:25
  26. Opus Genetics Reports Promising Early Results from BEST1 Gene Therapy Trial 2:37
  27. Eye on the Cure Podcast | Episode 100: BEST OF 35:57
  28. SparingVision Completes Dosing in Gene-Agnostic Therapy Trial for Retinitis Pigmentosa (RP) 2:32
  29. Blind & Beyond Radio Spotlight: Jason Menzo on Vision Research and Advocacy 15:28
  30. Eye on the Cure Podcast | Episode 99: Dr. Prem Subramanian 28:24
  31. Opus Genetics Receives Funding for Gene Therapy Clinical Trial for MERTK-Related RP 2:21
  32. AAVantgarde Completes Enrollment in Retinal Gene Therapy Trial for Usher Syndrome Type 1B 2:22
  33. SpliceBio Begins Dose-Expansion Phase of Clinical Trial for Stargardt Disease Protein Splicing Therapy 3:13
  34. Eye on the Cure Podcast | Episode 98: Jonathan & Josh Steinberg 47:01
  35. Eye on the Cure Podcast | Episode 97: Lindsey Rambo 39:37
  36. Beacon Therapeutics Launches Clinical Trial for Bilateral Administration of XLRP Gene Therapy 2:12
  37. Eye on the Cure Podcast | Episode 96: Dr. Deniz Dalkara 43:36
  38. Belite Bio to Seek FDA Approval for its Stargardt Disease Drug 3:06
  39. Opus Genetics Launches Gene Therapy Clinical Trial for Best Disease 2:39
  40. Eye on the Cure Podcast | Episode 95: Greta Streimikyte 20:49
  41. Eye on the Cure Podcast | Episode 94: Dr. Victoria Claire 53:56
  42. SparingVision Launches Clinical Trial for Therapy to Re-Activate Dormant Cones in Advanced RP 4:23
  43. Eye on the Cure Podcast | Episode 93: Sam Seavey 41:57
  44. Sepul Bio’s LCA10 RNA Therapy Moves into Phase 3 Clinical Trial 3:20
  45. Opus Reports Vision Improvements for Three Pediatric Patients in Phase 1/2 Clinical Trial for LCA5 Gene Therapy 4:26
  46. Eye on the Cure Podcast | Episode 92: Lance Baldo, MD 30:52
  47. Agnes Gund – Renowned Philanthropist, Social Justice Champion, and Art Patron – Passes Away 2:57
  48. Nacuity’s Antioxidative Therapy NACA Performs Encouragingly in Phase 1/2 Clinical Trial 3:37
  49. Eye on the Cure Podcast | Episode 91: Dr. George Magrath 22:19
  50. Opus Genetics Receives FDA Clearance to Launch Clinical Trial for Best1 Gene Therapy 2:07